Lab Report
Final report
Released by Dr. S. Raman · Consultant Pathologist
Patient details
| Patient name | Specimen Patient | Age / Sex | 42y · Female |
| UHID | SUN-P-004821 | Report ID | SPECIMEN-SUN-LB-00218 |
| Referred by | Dr. R. Kumar, MD | Report date | 24 Aug 2026 |
| Contact | +91 90000 00000 | ||
| Package | Women's Health Checkup | ||
| Collection address | No 12, 4th Cross Street, Chrompet, Chennai 600044 | ||
Sample & processing provenance
Processed atSunrise Diagnostics · 12 Main Road, Chrompet, Chennai 600044
| Sample | Accession | Barcode | Collected | Received (accessioned) | Released |
|---|---|---|---|---|---|
| SERUM | FQ177333 | FQ177333 | 24 Aug 2026 07:34 | 24 Aug 2026 11:11 | 24 Aug 2026 18:22 |
| URINE | FQ737947 | FQ737947 | 24 Aug 2026 07:34 | 24 Aug 2026 11:09 | 24 Aug 2026 13:24 |
| EDTA Whole Blood | FT666472 | FT666472 | 24 Aug 2026 07:34 | 24 Aug 2026 11:13 | 24 Aug 2026 12:52 |
| FLUORIDE PLASMA | FR839840 | FR839840 | 24 Aug 2026 07:34 | 24 Aug 2026 11:15 | 24 Aug 2026 12:35 |
NABL From 2019ISO 9001:2015 — From 2021
Summary — at a glance
Findings outside reference range (12)
| Test | Result | Reference | Status |
|---|---|---|---|
| Haemoglobin (Hb) | 11.2 g/dL | 12 – 15 | Low |
| Haematocrit (HCT / PCV) | 34.8 % | 36 – 46 | Low |
| RBC Distribution Width (RDW) | 14.6 % | 11.6 – 14 | High |
| HbA1c (Glycated Haemoglobin) | 6.2 % | < 5.7 | High |
| Estimated Average Glucose (eAG) | 131 mg/dL | 90 – 120 | High |
| Total Cholesterol | 216 mg/dL | < 200 | High |
| HDL (Good Cholesterol) | 37 mg/dL | 50 – 60 | Low |
| LDL (Bad Cholesterol) | 149 mg/dL | < 100 | High |
| Triglycerides | 168 mg/dL | < 150 | High |
| Non-HDL Cholesterol | 179 mg/dL | < 130 | High |
| Vitamin D (25-OH) | 13.8 ng/mL | 30 – 100 | Low |
| Serum Creatinine | 0.58 mg/dL | 0.72 – 1.18 | Low |
Detailed results
Complete Blood CountSample: EDTA Whole Blood · FT666472
| Parameter | Result | Unit | Reference | Flag |
|---|---|---|---|---|
| Haemoglobin (Hb)SLS-Haemoglobin method | 11.2 | g/dL | 12 – 15 | Low |
| Haematocrit (HCT / PCV)Calculated (RBC × MCV) | 34.8 | % | 36 – 46 | Low |
| Total RBC countHydrodynamic focusing & electrical impedance | 4.05 | ×10⁶/µL | 4 – 5.2 | |
| Mean Corpuscular Volume (MCV)Calculated (HCT / RBC × 10) | 86 | fL | 83 – 101 | |
| Mean Corpuscular Haemoglobin (MCH)Calculated (Hb / RBC × 10) | 27.7 | pg | 27 – 32 | |
| MCH Concentration (MCHC)Calculated (Hb / HCT × 100) | 32.2 | g/dL | 31.5 – 34.5 | |
| Red Cell Distribution Width – SD (RDW-SD)Measured (histogram-derived) | 46.8 | fL | 39 – 46 | High |
| RBC Distribution Width (RDW)Measured (histogram-derived) | 14.6 | % | 11.6 – 14 | High |
| Red Cell Distribution Width Index (RDWI)Calculated (MCV × RDW-CV / RBC) | 310.1 | Refer interpretation note | ||
Reference & interpretation RDWI >220: more likely Iron Deficiency Anaemia (IDA); RDWI <220: more likely Beta Thalassemia Trait (BTT) Note: Computed (LIMS) — cross-checked with the lab value | ||||
| Mentzer IndexCalculated (MCV / RBC) | 21.2 | Refer interpretation note | ||
Reference & interpretation MI >13: more likely Iron Deficiency Anaemia (IDA); MI <13: more likely Beta Thalassemia Trait (BTT) Note: Computed (LIMS) — cross-checked with the lab value | ||||
| Total Leucocyte Count (TLC)Hydrodynamic focusing & flow cytometry | 8.42 | ×10³/µL | 4 – 10 | |
| Neutrophils %Flow cytometry | 60.5 | % | 40 – 80 | |
| Lymphocytes %Flow cytometry | 33.6 | % | 20 – 40 | |
| Monocytes %Flow cytometry | 3.7 | % | 2 – 10 | |
| Eosinophils %Flow cytometry | 1.8 | % | 1 – 6 | |
| Basophils %Flow cytometry | 0.2 | % | 0 – 2 | |
| Absolute Neutrophil CountCalculated (Neutrophil% × WBC) | 5.09 | 10³/µL | 2 – 7 | |
Note: Computed (LIMS) — cross-checked with the lab value | ||||
| Platelet CountHydrodynamic focusing & electrical impedance | 231 | ×10³/µL | 150 – 410 | |
| Mean Platelet Volume (MPV)Measured (impedance) | 9.7 | fL | 6.5 – 12 | |
DiabetesSample: EDTA Whole Blood · FT666472
| Parameter | Result | Unit | Reference | Flag |
|---|---|---|---|---|
| HbA1c (Glycated Haemoglobin)Fully automated HPLC | 6.2 | % | < 5.7 | High |
Reference & interpretation Normal <5.7%; Prediabetes 5.7–6.4%; Diabetes ≥6.5% (ADA). Known diabetics: <6.5% good, 6.5–7% fair, 7–8% unsatisfactory, >8% poor control | ||||
| Estimated Average Glucose (eAG)Derived from HbA1c | 131 | mg/dL | 90 – 120 | High |
Reference & interpretation 90–120 mg/dL good control; 121–150 fair; 151–180 unsatisfactory; >180 poor control Note: Computed (LIMS) — cross-checked with the lab value | ||||
| Fasting Blood Sugar (FBS)Photometry (hexokinase / GOD-POD) | 96.4 | mg/dL | 70 – 100 | |
Reference & interpretation Normal 70–100 mg/dL; Prediabetes 100–125 mg/dL; Diabetes ≥126 mg/dL (ADA) | ||||
Lipid ProfileSample: SERUM · FQ177333
| Parameter | Result | Unit | Reference | Flag |
|---|---|---|---|---|
| Total CholesterolCHOD-PAP (enzymatic) | 216 | mg/dL | < 200 | High |
Reference & interpretation <200: Desirable | 200–239: Borderline high | ≥240: High | ||||
| HDL (Good Cholesterol)Direct (accelerator selective detergent / enzymatic) | 37 | mg/dL | 50 – 60 | Low |
Reference & interpretation <40 (M) / <50 (F): Low (higher risk) | ≥60: High (protective) | ||||
| LDL (Bad Cholesterol)Direct (selective detergent / enzymatic) | 149 | mg/dL | < 100 | High |
Reference & interpretation <100: Optimal | 100–129: Near optimal | 130–159: Borderline high | 160–189: High | ≥190: Very high | ||||
| TriglyceridesGPO-PAP (enzymatic) | 168 | mg/dL | < 150 | High |
Reference & interpretation <150: Normal | 150–199: Borderline high | 200–499: High | ≥500: Very high | ||||
| Total Cholesterol / HDL RatioCalculated (Total cholesterol / HDL) | 5.8 | ratio | < 4.4 | High |
Reference & interpretation <3.5: Low risk | 3.5–5.0: Average risk | >5.0: High risk Note: Computed (LIMS) — cross-checked with the lab value | ||||
| Non-HDL CholesterolCalculated (Total cholesterol − HDL) | 179 | mg/dL | < 130 | High |
Reference & interpretation <130: Optimal | 130–159: Above optimal | 160–189: Borderline high | 190–219: High | ≥220: Very high Note: Computed (LIMS) — cross-checked with the lab value | ||||
| VLDL CholesterolCalculated (Triglycerides / 5) | 34 | mg/dL | 0 – 30 | High |
Note: Computed (LIMS) — cross-checked with the lab value | ||||
| Remark Atherogenic pattern with a low HDL. Suggest correlation with clinical risk factors and repeat after lifestyle modification in 8–12 weeks. | ||||
Liver FunctionSample: SERUM · FQ177333
| Parameter | Result | Unit | Reference | Flag |
|---|---|---|---|---|
| ALP (Alkaline Phosphatase)IFCC, p-NPP, AMP buffer | 96.4 | U/L | 35 – 104 | |
| Bilirubin (Total)Diazo / oxidation (DPD) | 0.42 | mg/dL | 0.3 – 1.2 | |
| Bilirubin (Direct)Diazo method | 0.06 | mg/dL | 0 – 0.3 | |
| Bilirubin (Indirect)Derived from total and direct bilirubin | 0.36 | mg/dL | 0.1 – 0.9 | |
Note: Computed (LIMS) — cross-checked with the lab value | ||||
| SGOT / ASTIFCC without P5P (UV kinetic) | 15.4 | U/L | 0 – 32 | |
| SGPT / ALTIFCC without P5P (UV kinetic) | 15.5 | U/L | 0 – 33 | |
| SGOT / SGPT RatioDerived from SGOT and SGPT | 0.99 | ratio | < 1.0 | |
Note: Computed (LIMS) — cross-checked with the lab value | ||||
| Total ProteinBiuret method | 6.67 | g/dL | 6.3 – 8.2 | |
| AlbuminBCG (bromocresol green) | 3.8 | g/dL | 3.5 – 5 | |
| GlobulinDerived from total protein and albumin | 2.87 | g/dL | 2 – 3.5 | |
Note: Computed (LIMS) — cross-checked with the lab value | ||||
Kidney Function & ElectrolytesSample: SERUM · FQ177333
| Parameter | Result | Unit | Reference | Flag |
|---|---|---|---|---|
| Blood Urea Nitrogen (BUN)Photometry | 9.42 | mg/dL | 7.94 – 20.07 | |
| Serum CreatininePhotometry | 0.58 | mg/dL | 0.72 – 1.18 | Low |
| Sodium (Na⁺)Indirect ISE (ion selective electrode) | 140.7 | mmol/L | 136 – 145 | |
| Potassium (K⁺)Indirect ISE (ion selective electrode) | 4.3 | mmol/L | 3.5 – 5.1 | |
| Chloride (Cl⁻)Indirect ISE (ion selective electrode) | 104.6 | mmol/L | 98 – 107 | |
| Estimated GFR (eGFR)Calculated (CKD-EPI) | 111 | mL/min/1.73m² | > 90 | |
Reference & interpretation ≥90: Normal | 60–89: Mild decrease | 45–59: Mild to moderate | 30–44: Moderate to severe | 15–29: Severe | <15: Kidney failure Note: Computed (LIMS) — cross-checked with the lab value | ||||
ThyroidSample: SERUM · FQ177333
| Parameter | Result | Unit | Reference | Flag |
|---|---|---|---|---|
| Total T3 (Triiodothyronine)C.M.I.A | 127 | ng/dL | 58 – 159 | |
| Total T4 (Thyroxine)C.M.I.A | 8 | µg/dL | 4.87 – 11.72 | |
| TSH (Thyroid Stimulating Hormone)C.M.I.A | 2.28 | µIU/mL | 0.35 – 4.94 | |
Reference & interpretation <0.35: Low (hyperthyroidism); 0.35–4.94: Normal (euthyroid); >4.94: High (hypothyroidism / subclinical hypothyroidism) | ||||
VitaminsSample: SERUM · FQ177333
| Parameter | Result | Unit | Reference | Flag |
|---|---|---|---|---|
| Vitamin D (25-OH)C.M.I.A | 13.8 | ng/mL | 30 – 100 | Low |
Reference & interpretation Deficiency: <20; Insufficiency: 20–30; Sufficiency: 30–100; Toxicity: >100 ng/mL | ||||
| Vitamin B12C.M.I.A | 317 | pg/mL | 187 – 883 | |
Reference & interpretation Deficient: <187; Borderline: 187–300; Normal: >300 pg/mL | ||||
| Folate (Folic Acid)C.M.I.A | 10.9 | ng/mL | 3 – 20 | |
Urine RoutineSample: URINE · FQ737947
| Parameter | Result | Unit | Reference | Flag |
|---|---|---|---|---|
| ColourVisual determination | Pale yellow | Pale yellow | ||
| AppearanceVisual determination | Clear | Clear | ||
| Specific GravitypKa change (indicator) | 1.010 | 1.003 – 1.030 | ||
| pHpH indicator | 5.5 | 5 – 8 | ||
| Protein / AlbuminProtein error of indicators (PEI) | ABSENT | Absent / Nil | ||
| Urinary GlucoseGOD-POD | ABSENT | Absent / Nil | ||
| WBC (Pus Cells)Microscopy | 1 | /HPF | 0 – 5 | |
| RBC (Erythrocytes)Microscopy | ABSENT | /HPF | 0 – 2 |
Cumulative results — previous values
Serial values from this patient's earlier reports at this laboratory, oldest first; today's result is the last point. For clinical correlation.
Haemoglobin (Hb) (g/dL)
Previous: 12.2 g/dL (12 Jun)
| 12.2 | 11.2 Low |
| 12 Jun | 24 Aug |
HbA1c (Glycated Haemoglobin) (%)
Previous: 5.8 % (12 Jun)
| 5.8 High | 6.2 High |
| 12 Jun | 24 Aug |
What this means
Most systems — thyroid, liver and kidney — are working normally. Three things need attention: your cholesterol pattern, a blood sugar reading in the prediabetes range, and a low vitamin D.
Your haemoglobin is a little below range and has come down slightly since June, which is worth repeating with an iron study. HbA1c at 6.2% sits in the prediabetes band, and the lipid pattern — a high LDL with a low HDL — adds to cardiovascular risk. Vitamin D is deficient. None of these is an emergency; together they make a clear case for a review with your doctor.
Suggested next steps
- Discuss these results with your doctor, particularly the lipid pattern and the HbA1c.
- A diet lower in refined carbohydrates and fried food, with more whole grains, pulses and vegetables.
- 30–45 minutes of moderate activity on most days.
- Ask your doctor about correcting the vitamin D deficiency and about repeating the haemoglobin with an iron study.
AI-generated interpretation, pending doctor review. Educational only — not a diagnosis; please consult your doctor.
— End of Report —
Verify this report. Scan the code, or visit pingmedoc.com/verify and enter SPECIMEN-SUN-LB-00218. A genuine report matches these details online; an altered copy will not. Scanning also opens your own secure copy of this report, after a one-time code sent to your registered mobile.
Digitally generated & tamper-evident — issued electronically via the PingMeDoc platform for Sunrise Diagnostics. No manual alteration is valid.
This is a SPECIMEN report produced by PingMeDoc lab software to show how a report prints. It describes no real patient and no real sample, and it is not a valid diagnostic document. On a genuine report this line carries the issuing laboratory's own disclaimer.